Skip to main content
    P

    Processa Pharmaceuticals Inc (PCSA)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.72
    -0.14 (-7.53%)

    Market Cap: $5.20M

    Last updated: Nov 17, 2026 at 11:00 AM ET

    Processa Pharmaceuticals Inc (PCSA) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Processa Pharmaceuticals are Traws Pharma (TRAW), CNS Pharmaceuticals (CNSP) and Aprea Therapeutics (APRE). By market cap, Processa Pharmaceuticals ranks 6th of the 13 companies on this page; Phio Pharmaceuticals (PHIO) is the largest at $9.21M.

    Peer Comparison

    PCSA's revenue growth of 0.0% is in line with the peer median. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Processa Pharmaceuticals (PCSA)$5.20MN/AN/A0.0%N/A0.0%0.00%
    Traws Pharma Inc (TRAW)$3.86MN/AN/A0.0%N/A-100.0%0.00%
    CNS Pharmaceuticals Inc (CNSP)$4.22MN/AN/A0.0%N/A0.0%0.00%
    Aprea Therapeutics Inc (APRE)$5.91MN/AN/A0.0%N/A-98.4%0.00%
    Phio Pharmaceuticals Corp (PHIO)$9.21MN/AN/A0.0%N/A0.0%0.00%
    PharmaCyte Biotech Inc (PMCB)$3.77MN/AN/A0.0%N/A0.0%0.00%
    Theriva Biologics Inc. (TOVX)$6.61MN/A21.5x0.0%-52.3%0.0%0.00%
    Tempest Therapeutics Inc (TPST)$7.64MN/AN/A0.0%-783.6%0.0%0.00%
    Pulmatrix Inc (PULM)$4.71MN/AN/A0.0%N/A-99.9%0.00%
    Reviva Pharmaceuticals Holdings Inc. (RVPH)$4.63MN/AN/A0.0%-90.2%0.0%0.00%
    Liminatus Pharma, Inc. Class A Common Stock (LIMN)$4.02MN/AN/A0.0%-247.2%0.0%0.00%
    Lantern Pharma Inc (LTRN)$6.47MN/AN/A0.0%N/A0.0%0.00%
    Galmed Pharmaceuticals Ltd (GLMD)$4.95MN/AN/A0.0%N/A0.0%N/A
    Peer median$4.83MN/A21.5x0.0%-168.7%0.0%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Processa Pharmaceuticals, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.

    CompanyAboutPeers
    Traws Pharma Inc (TRAW)
    Traws Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel products to treat cancer in the United States.
    TRAW competitors
    CNS Pharmaceuticals Inc (CNSP)
    CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, is dedicated to the development of cancer drug candidates for the treatment of brain and central...
    CNSP competitors
    Aprea Therapeutics Inc (APRE)
    Aprea Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops and markets cancer therapies that reactivate the mutant p53 tumor suppressor...
    APRE competitors
    Phio Pharmaceuticals Corp (PHIO)
    Phio Pharmaceuticals Corp. The company is headquartered in Marlborough, Massachusetts.
    PHIO competitors
    PharmaCyte Biotech Inc (PMCB)
    PharmaCyte Biotech, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cell therapies for cancer and diabetes in the United...
    PMCB competitors
    Theriva Biologics Inc. (TOVX)
    Theriva Biologics Inc., a clinical-stage company, develops therapies to treat diseases in areas of high unmet need.
    TOVX competitors
    Tempest Therapeutics Inc (TPST)
    Tempest Therapeutics Inc., a clinical-stage oncology company, is dedicated to the development of small molecules that combine targeted and immune-mediated...
    TPST competitors
    Pulmatrix Inc (PULM)
    Pulmatrix, Inc., a clinical-stage biopharmaceutical company, discovers and develops inhaled therapies to prevent and treat respiratory and other diseases...
    PULM competitors
    Reviva Pharmaceuticals Holdings Inc. (RVPH)
    Reviva Pharmaceuticals Holdings Inc. (RVPH) is a clinical-stage biopharmaceutical company dedicated to developing groundbreaking therapies for central nervous...
    RVPH competitors
    Liminatus Pharma, Inc. Class A Common Stock (LIMN)
    Liminatus Pharma, Inc. is a clinical-stage immuno-oncology company that develops novel cancer therapies. The company is headquartered in LA Palma, California.
    LIMN competitors
    Lantern Pharma Inc (LTRN)
    Lantern Pharma Inc., a clinical-stage biotechnology company, focuses on developing precision cancer therapies using artificial intelligence, genomics...
    LTRN competitors
    Galmed Pharmaceuticals Ltd (GLMD)
    Galmed Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company, focuses on the development of therapies for the treatment of liver diseases.

    Frequently Asked Questions About PCSA

    Who are Processa Pharmaceuticals' main competitors?

    The companies most similar to Processa Pharmaceuticals include Traws Pharma (TRAW), CNS Pharmaceuticals (CNSP), Aprea Therapeutics (APRE), Phio Pharmaceuticals (PHIO) and PharmaCyte Biotech (PMCB), listed from the closest match.

    Who is Processa Pharmaceuticals' biggest competitor?

    Phio Pharmaceuticals (PHIO) is the largest of the similar companies at $9.21M; Traws Pharma (TRAW) is the closest match by business profile, size, sector and industry.

    How does PCSA stock compare with its competitors?

    PCSA's net margin is 0.0% against a peer median of 0.0%.

    Which of Processa Pharmaceuticals' competitors pays a higher dividend?

    Processa Pharmaceuticals pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.

    Is Processa Pharmaceuticals bigger than its competitors?

    No. Processa Pharmaceuticals is 6th by market cap among the 13 companies on this page; the largest is Phio Pharmaceuticals (PHIO) at $9.21M.